February 6, 2012Metabolix, Inc. • February 10th, 2012 • Miscellaneous plastics products
The undersigned (“we” or “us”) hereby advise Metabolix, Inc. (“Metabolix” or “you”) that, as of the date hereof, we may be deemed to have beneficial ownership of up to 5,091,295 shares (the “Initial Shares”), or approximately 14.9%, of the outstanding common stock, par value $0.01 per share (the “Common Stock”), of Metabolix, based on 34,113,882 shares of Common Stock outstanding on October 26, 2011 as reported in Metabolix’s Form 10-Q for the period ended September 30, 2011. This number consists of (i) 3,124,876 shares owned by Jack W. Schuler, (ii) 50,600 shares owned by Renate Schuler and (iii) 1,915,819 shares owed by the Schuler Family Foundation, a tax-exempt private operating foundation of which Jack W. Schuler and Renate Schuler serve as two of the three directors. We did not acquire and do not hold the Initial Shares with any purpose, or with the effect, of changing or influencing the control of Metabolix, or in connection with or as a participant in any transaction having tha
AMENDMENT NO. 1 TO SHAREHOLDER RIGHTS AGREEMENTShareholder Rights Agreement • February 10th, 2012 • Metabolix, Inc. • Miscellaneous plastics products • Delaware
This Amendment No. 1, effective as of February 6, 2012 (the “Amendment”), amends the Shareholder Rights Agreement, dated as of July 7, 2009 (the “Rights Agreement”), between Metabolix, Inc., a Delaware corporation (the “Company”), and American Stock Transfer & Trust Company LLC, a New York Limited Liability Trust Company (the “Rights Agent”). Capitalized terms used herein but not defined herein shall have their defined meanings set forth in the Rights Agreement.
